Pancreatic insufficiency resulting in maldigestion remained a real challenge to treat after more than100 years of practice with pancreatin preparations. Both proteolytic and acid inactivation of pancreatic enzymes have a role in the uneven results of replacement therapy. Only acid-protected preparations with physiological protease/lipase ratio, and optimal galenic properties to assure fast mixing and segregation of enzymes to their substrates,...